Top

Published in:

01-08-2016 | Original Article

Socioeconomic value of intervention for chronic pain

Authors: Tomoyuki Takura, Masahiko Shibata, Shinsuke Inoue, Yoichi Matsuda, Hironobu Uematsu, Keiko Yamada, Takahiro Ushida

Published in: Journal of Anesthesia | Issue 4/2016

Abstract

Purpose

The purpose of this study was to examine the cost-effectiveness of pain treatments in two pain centers in Japan.

Methods

The study population comprised 91 patients receiving various treatments for chronic pain, which were divided into three categories: (1) medication, (2) medication + nerve block, and (3) other modalities (exercise and/or pain education). Pain was assessed using the Pain Disability Assessment Scale (PDAS) score, Hospital Anxiety and Depression Scale (HADS) score, Pain Catastrophizing Scale (PCS) score, and EQ-5D score. First, the reliability of the EQ-5D score first assessed by evaluating the correlation this score with those of the other pain-related evaluation instruments, and then the cost effectiveness of the pain treatments was evaluated. Evaluation of medical costs was based on data provided from the Management Services of the hospital, which in turn were based on national health scheme medical treatment fees. The quality-adjusted life year (QALY) value was calculated from the EQ-5D score, converted to 12 months, and then used for cost-benefit analysis along with medical treatment fees.

Results

According to the recent IASP classification, more patients had chronic neuropathic pain (41) than chronic primary pain (37 patients) or chronic musculoskeletal pain (27 patients). There was a significant correlation between the EQ-5D score and the PDAS, HADS, and PCS scores, which demonstrated the reliability of the EQ-5D score. Significant improvement in the HADS, PCS, and EQ-5D scores was noted after 3 months of pain treatment. Calculation of the cost-effectiveness based on the estimated annual medical treatment cost and QALY revealed a mean value of US $45,879 ± 103,155 per QALY (median US $16,903), indicating adequate socioeconomic utility.

Conclusion

Based on our results, the EQ-5D is reliable for evaluating chronic pain in patients. The medico-economic balance was appropriate for all treatments provided in two comprehensive pain centers in Japan.

Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain. 2012;13:715–24.CrossRefPubMed

Gannon B, Finn DP, O’Gorman D, Ruane N, McGuire BE. The cost of chronic pain: an analysis of a regional pain management service in Ireland. Pain Med. 2013;14:1518–28.CrossRefPubMed

Knight T, Schaefer C, Chandran A, Zlateva G, Winkelmann A, Perrot S. Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. Clinicoecon Outcomes Res. 2013;5:171–80.CrossRefPubMedPubMedCentral

Langley PC, Van Litsenburg C, Cappelleri JC, Carroll D. The burden associated with neuropathic pain in Western Europe. J Med Econ. 2013;16:85–95.CrossRefPubMed

Maas ET, Juch JN, Groeneweg JG, Ostelo RW, Koes BW, Verhagen AP, van Raamt M, Wille F, Huygen FJ, van Tulder MW. Cost-effectiveness of minimal interventional procedures for chronic mechanical low back pain: design of four randomised controlled trials with an economic evaluation. BMC Musculoskelet Disord. 2012;13:260.CrossRefPubMedPubMedCentral

North RB, Shipley J, Wang H, Mekhail N. A review of economic factors related to the delivery of health care for chronic low back pain. Neuromodulation. 2014[Suppl 17];2:69–76.

Obradovic M, Ikenberg R, Hertel N, Antonanzas F, Galvez R, Liedgens H. Cost-effectiveness of tapentadol in severe chronic pain in Spain: a cost analysis of data from RCTs. Clin Ther. 2012;34:926–43.CrossRefPubMed

Winkelmann A, Perrot S, Schaefer C, Ryan K, Chandran A, Sadosky A, Zlateva G. Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study. Appl Health Econ Health Policy. 2011;9:125–36.CrossRefPubMed

Cardosa M, Osman ZJ, Nicholas M, Tonkin L, Williams A, Abd AK, Mohd AR, Dahari NM. Self-management of chronic pain in Malaysian patients: effectiveness trial with 1-year follow-up. Transl. Behav Med. 2012;2:30–7.CrossRef

10.

Takura T, Yoshimatsu M, Sugimori H, Takizawa K, Furumatsu Y, Ikeda H, Kato H, Ogawa Y, Hamaguchi S, Fujikawa A, Satoh T, Nakajima Y. Cost-effectiveness analysis of percutaneous vertebroplasty for osteoporotic compression fractures. J Spinal Disord Tech. 2013;2013:16.

11.

Takura T, Nakanishi T, Kawanishi H, Nitta K, Akizawa T, Hiramatsu M, Kawasaki T, Kukita K, Soejima H, Hirakata H, Yoshida T, Miyamoto T, Takahashi S. Cost-effectiveness of maintenance hemodialysis in Japan. Ther Apher Dial. 2015;9:441–9.

12.

Wielage R, Bansal M, Wilson K, Klein R, Happich M. Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective. Spine (Phila Pa 1976). 2013;38:936–946.

13.

Manchikanti L, Falco FJ, Pampati V, Cash KA, Benyamin RM, Hirsch JA. Cost utility analysis of caudal epidural injections in the treatment of lumbar disc herniation, axial or discogenic low back pain, central spinal stenosis, and post lumbar surgery syndrome. Pain Physician. 2013;16:E129–43.PubMed

14.

Manchikanti L, Helm S 2nd, Pampati V, Racz GB. Cost utility analysis of percutaneous adhesiolysis in managing pain of post-lumbar surgery syndrome and lumbar central spinal stenosis. Pain Pract. 2015;15:414–22.CrossRefPubMed

15.

Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, Finnerup NB, First MB, Giamberardino MA, Kaasa S, Kosek E, Lavand’homme P, Nicholas M, Perrot S, Scholz J, Schug S, Smith BH, Svensson P, Vlaeyen JW, Wang SJ. A classification of chronic pain for ICD-11. Pain. 2015;156:1003–7.PubMedPubMedCentral

16.

Edejer T, Baltussen R, Adam R, Hutubessy R, Acharya A, Evans DB, Murray CJL, Methods for generalized cost-effectiveness analysis. In: WHO Guide to cost-effectiveness analysis. 2003. World Health Organization, Geneva, pp 3–16.

17.

Takura T. Cost-effectiveness of hemodialysis in Japan. Contrib Nephrol. 2015;185:124–31.PubMed

18.

Takura T, Hayashi M, Muragaki Y, Iseki H, Uetsuka Y. Study on medical economic evaluation methods for metastatic brain tumors therapy (in Japanese with English abstract). No Shinkei Geka (Jpn J Anesthesiol). 2010;38:629–37.

19.

EuroQol Group. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.CrossRef

20.

Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, Vasoo S, Li SC, Thumboo J. A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease. J Rheumatol. 2003;30:2268–74.PubMed

21.

Schweikert B, Hahmann H, Leidl R. Validation of the EuroQol questionnaire in cardiac rehabilitation. Heart. 2006;92:62–7.CrossRefPubMed

22.

Takura T, Nakanishi T, Kawanishi H, Nitta K, Akizawa T, Hiramatsu M, Kawasaki T, Kukita K, Soejima H, Hirakata H, Yoshida T, Miyamoto T, Takahashi S. Cost-Effectiveness of Maintenance Hemodialysis in Japan. Ther Apher Dial. 2015;19:441–9.CrossRefPubMed

Title: Socioeconomic value of intervention for chronic pain
Authors: Tomoyuki Takura
Masahiko Shibata
Shinsuke Inoue
Yoichi Matsuda
Hironobu Uematsu
Keiko Yamada
Takahiro Ushida
Publication date: 01-08-2016
Publisher: Springer Japan
Published in: Journal of Anesthesia / Issue 4/2016
Print ISSN: 0913-8668
Electronic ISSN: 1438-8359
DOI: https://doi.org/10.1007/s00540-016-2162-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Socioeconomic value of intervention for chronic pain

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2016

In reply: Comparing face-to-face intubation with different devices

Emergency bronchoscopy for foreign-body aspiration in a child with type I mucopolysaccharidosis: a challenging airway management experience

Regional block: who first thought of such an approach?

The efficacy of simultaneous bilateral axillary brachial plexus block under the guidance of neurostimulator or ultrasound: a prospective study

Work of breathing using different interfaces in spontaneous positive pressure ventilation: helmet, face-mask, and endotracheal tube

Pharmacokinetics and systemic toxicity of local anesthetics in children